Like alien invaders in a sci-fi movie, pancreatic cancer cells quickly adapt to the weapons used against them and find ways to survive, even in the harshest of conditions.
Understanding why is the aim of cancer scientists everywhere. A researcher recently advanced the knowledge of pancreatic cancer with a study about how it acclimates to and even thrives in a highly acidic environment. The research is published in the current issue of the journal Nature Cell Biology.
“Very few studies have tried to understand how that acidification contributes to tumor cell viability and what adaptations tumor cells undergo so that they are able to grow and sustain their aggressiveness,” said the study’s lead author.
Cancer is part of a tumor microenvironment – an ecosystem of normal cells, molecules and blood vessels that surround it, each affecting the other in ways both bad and good. In pancreatic cancer, the microenvironment is acidic because tumor cells consume a lot of the body’s glucose and then churn out an overabundance of lactic acid. As a whole, the tumor microenvironment is inhospitable because the cancer has deprived it of oxygen and nutrients due to its out-of-control growth. Yet pancreatic cancer constantly devises new ways to survive.
In his research, the researcher discovered a series of steps that occur that allow pancreatic cancer to use the acidic environment to its advantage:
-
Cancer-associated fibroblasts, a type of cell in the tumor, secrete a molecule called acetate.
-
Pancreatic cancer cells use the acetate for “epigenetic reprogramming,” altering the way that genes work.
-
One of those genes, called SAT1, is activated by acetate and essentially gives cancer cells the tools they need to better grow in acidic conditions.
Understanding the mechanisms that help tumor cells to adapt and thrive is the foundation for devising treatments that could stop the process somewhere along the way, the author said. In this case, it may be possible to target SAT1 with a drug that can decrease the fitness of tumor cells to grow in the acidic microenvironment. The author is continuing studies by repurposing a pneumonia drug called pentamidine to test its effectiveness in decreasing pancreatic tumor aggressiveness in mice.
Pancreatic cancer remains one of the deadliest cancers – the five-year survival rate is just under 13%, according to the National Cancer Institute – and treatment options are few. Basic science research is crucial for continuing the unravel the devious nature of the cancer.
“This study highlights the fact that pancreatic tumor cells are not acting alone,” the author said. “They have co-culprits in other cells, which they hijack and reprogram to their own advantage. By understanding these mechanisms, we can perhaps come up with better therapeutic approaches to target cancer.”
https://www.nature.com/articles/s41556-024-01372-4
Latest News
Protease action on controll…
By newseditor
Posted 25 May
Maternal inflammation activ…
By newseditor
Posted 25 May
How cells deal with extra c…
By newseditor
Posted 25 May
Flicker stimulation modulat…
By newseditor
Posted 25 May
Multi-dose TB vaccines prot…
By newseditor
Posted 24 May
Other Top Stories
CRISPR-based test for COVID-19 uses a smartphone camera
Read more
How COVID-19 virus causes multiple organ failure in mice
Read more
A leukemia patient sheds infectious SARS-CoV-2 for at least 70 days
Read more
A host factor that helps viruses replicate and infect other cells i…
Read more
Gut microbiota act via endocannabinoid system to regulate depressiv…
Read more
Protocols
Spatially resolved lipidomi…
By newseditor
Posted 24 May
Efficient expansion and CRI…
By newseditor
Posted 21 May
Massively parallel in vivo…
By newseditor
Posted 20 May
Breast cancer-on-chip for p…
By newseditor
Posted 16 May
Methods for making and obse…
By newseditor
Posted 15 May
Publications
Cryo-EM reveals that iRhom2…
By newseditor
Posted 25 May
Fetal brain response to mat…
By newseditor
Posted 25 May
Children born after assiste…
By newseditor
Posted 25 May
Macrophage-induced integrin…
By newseditor
Posted 25 May
Copy number alterations: a…
By newseditor
Posted 25 May
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar